Boston Society Gene and Cell Therapy Conference 

Remote attendance alternative will also be provided to accommodate those unable to travel!


March 21, 2024

Venue Changed to: Museum of Science

The d'Arbeloff Suite (3rd floor/RED WING)

Address: 1 Science Park, Boston, MA 02114




          In Partnership with:


      In Partnership with:

Confirmed Speakers

Keynote Lecture: 

Mark Milton, PhD

Former Global Head Gene Therapies, PK Sciences @ Novartis Institutes for BioMedical Research - Retired

Past, Present, and Future of Gene Therapy


Glen Banks, PhD

Cardiac Gene Therapy Lead @ Bristol Myers Squibb

Preclinical Considerations for Development of GTx


Nicholas Buss, PhD

Translational Sciences @ Eli Lilly

Gene Therapy and Translational Sciences - How are we doing?


Nagendra Chemuturi, PhD

Senior Director ADME @ Eli Lilly

Role of DMPK in non-viral GT

Jennifer Ford, PhD

Clinical Pharmacology and Pharmacometrics @ The Janssen Pharmaceutical Companies of Johnson & Johnson

Development of AAV-Based Retina Gene Therapy through the Eyes of the Clinical Pharmacologist


Jennifer Jones, PhD

Head of Companion Diagnostics @ Spark Therapeutics

Pre-existing antibody assays for patient enrollment and Cdx - Title TBA


Jyoti Malhotra, PhD

Executive Director @ Sarepta Therapeutics

Learnings from Duchenne Muscular Dystrophy: A Biomarker Perspective


Ronit Mazor, PhD

Principal Investigator @ OGT, OTP,CBER, US Food and Drug Administration

Can the Immunogenicity of AAV Vectors be Mitigated? 

Kenji Miyazawa, PhD

Scientist QSP @ Moderna

Construction of an Integrated Translational PBPK-QSP Modeling Platform to Investigate Tissue Distribution & Protein Expression Dynamics of LNP-mRNA Based Therapeutics


Yan Ni, PhD

Executive Director, Biomarkers & Precision Medicine @ Passage Bio

Leveraging Clinical Diagnostic Assays for Rare Disease Drug Development


Lei Ci, PhD

Associate Scientific Director @ Moderna

Assessment of ADME and DDI for LNP-mRNA Therapeutics


Everett Perkins, PhD

Executive Director - ADME @ Eli Lilly and Company

ADME for In Vivo Genetic Editing: Assessing Effectiveness of Delivery for Editing Cargo

R. Jude Samulski, PhD

Alumni Distinguished Professor, Pharmacology, Member, UNC Gene Therapy Center @ UNC School of Medicine

Development of Viral Delivery for Precision Medicine

Brian Wile, PhD

General Manager, FlowMetric a KCAS Company

Troubleshooting in Flow Cytometry Method Development: Ions, Titers, and Bears (Oh My!)




Please Join our LinkedIn Group


Session I: Current State-of-the-Art Gene Delivery

Session II: Translational PK/PD and Clinical Pharmacology Aspects

Session III: Biomarkers and Clinical Translation Aspects of Gene Therapy


Click here to register for the Gene and Cell Therapy conference online.

The conference will take place March 21, 2024 at:

BMS, Cambridge Crossing, Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy